Iovance posts updated corporate presentation for August 2025; no specific details disclosed

IOVANCE BIOTHERAPEUTICS, INC.

Company filed an 8-K announcing a revised corporate presentation dated August 2025.
Presentation is used at healthcare conferences and for discussions with analysts and stockholders.
Exhibit 99.1 incorporated by reference but full content not provided in this filing excerpt.
No financial or clinical milestones were explicitly stated in the filing body.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.